True Wealth Design’s Kura Oncology KURA Stock Holding History

True Wealth Design’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$11.1K	Sell	1,038 -204	-16%	-$2.28K	﹤0.01%	1029
2026 Q2	$13.6K	Buy	1,242 +375	+43%	+$3.54K	﹤0.01%	955
2026 Q1	$7.05K	Sell	867 -462	-35%	-$3.97K	﹤0.01%	1091
2025 Q4	$13.8K	Buy	1,329 +497	+60%	+$5.22K	﹤0.01%	741
2025 Q3	$7.36K	Buy	832 +17	+2%	+$121	﹤0.01%	945
2025 Q2	$4.7K	Sell	815 -437	-35%	-$2.68K	﹤0.01%	832
2025 Q1	$8.26K	Buy	1,252 +1,243	+13,811%	+$9.7K	﹤0.01%	534
2024 Q4	$79	Sell	9 -101	-92%	-$1.45K	﹤0.01%	1293
2024 Q3	$2.15K	Buy	+110	New	+$2.23K	﹤0.01%	765

Other funds holding KURA

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return

Flower City Capital Pittsford, New York $234M AUM 15.69% 1-Year Est. Return

NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return

Sanders Morris Harris Houston, Texas $755M AUM 11.28% 1-Year Est. Return

Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

True Wealth Design's KURA Position: Q3 2026 in Review

True Wealth Design reduced its Kura Oncology (KURA) stake by 16% in Q3 2026, selling an estimated $2.28K and leaving 1,038 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1029.

True Wealth Design first reported a position in KURA in Q3 2024 and has held it in 9 quarters since. The position peaked at $13.8K in Q4 2025. 22 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

True Wealth Design held 1,038 shares of Kura Oncology worth $11.1K as of Q3 2026.
True Wealth Design sold 204 Kura Oncology shares in Q3 2026, an estimated $2.28K.
Kura Oncology made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #1029 holding.
True Wealth Design first reported a position in Kura Oncology in Q3 2024 and has held it in 9 quarters since.
True Wealth Design's Kura Oncology position peaked at $13.8K in Q4 2025.
22 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.